Abstract
It is the aim of this chapter to review the major advances that occurred during 1975 with regard to our knowledge about the metabolism of the major plasma lipids and lipoproteins, and about clinical abnormalities in lipid transport, with particular emphasis on the hyperlipidemias. In addition, some recent major developments that occurred before 1975 will be reviewed briefly in order to provide important background information. The well-established association between the presence of hyperlipidemia and an increased risk of the development of coronary heart disease (Kannel et al., 1961, 1971; Carlson and Böttiger, 1972) has served to stimulate both biochemists and clinicians to focus considerable research efforts on this area.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahrens, E. H., Jr., 1974, Homozygous hypercholesteremia and the portacaval shunt: The need for a concerted attack by surgeons and clinical researchers, Lancet 2: 449–451.
Bagdade, J. D., Porte, D., Jr., and Bierman, E. L., 1968, Hypertriglyceridemia: A metabolic consequence of chronic renal failure, N. Engl. J. Med. 279: 181–185.
Baker, H. N., Gotto, A. M., Jr., and Jackson, R. L., 1975, The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). II. The amino acid sequence and alignment of cyanogen bromide fragments IV, III, and I, J. Biol. Chem. 250: 2725–2738.
Beaumont, J. L., Carlson, L. A., Cooper, G. R., Fejfar, Z., Fredrickson, D. S., and Strasser, T., 1970, Classification of hyperlipidemias and hyperlipoproteinemias, Bull. W. H. O. 43: 891–915.
Beaumont, J. E., Luke, R. G., Galla, J. H., Rees, E. D., and Siegel, R. R., 1975, Normal serum-lipids in renal-transplant patients, Lancet 1: 599–601.
Bilheimer, D. W., Goldstein, J. L., Grundy, S. M., and Brown, M. S., 1975, Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia, J. Clin. Invest. 56: 1420–1430.
Blacket, R. B., Leelarthaepin, B., Woodhill, J. M., and Palmer, A. J., 1975, Type- IV hyperlipidemia and weight-gain after maturity, Lancet 2: 517–520.
Breslow, J. L., Spaulding, D. R., Lux, S. E., Levy, R. I., and Lees, R. S.,. 1975, Homozygous familial hypercholesterolemia: A possible biochemical explanation of clinical heterogeneity, N. Engl. J. Med. 293: 900–903.
Brewer, H. B., Jr., Shulman, R., Herbert, P., Ronan, R., and Wehrly, K., 1974, The complete amino acid sequence of alanine apolipoprotein (apoC-III), an apolipoprotein from human plasma very low density lipoproteins, J. Biol. Chem. 249: 4975–4984.
Brown, M. S., and Goldstein, J. L., 1974, Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol, J. Biol. Chem. 249: 7306–7314.
Brown, M. S., and Goldstein, J. L., 1975, Regulation of the activity of the low density lipoprotein receptor in human fibroblasts, Cell 6: 307–316.
Brown, M. S., Brannan, P. G., Bohmfalk, H. A., Brunschede, G. Y., Dana, S. E., Helgeson, J., and Goldstein, J. L., 1975a, Use of mutant fibroblasts in the analysis of the regulation of cholesterol metabolism in human cells, J. Cell. Physiol. 85: 425–436.
Brown, M. S., Faust, J. R., and Goldstein, J. L., 1975b, Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts, J. Clin. Invest. 55: 783–793.
Brunzell, J. D., Hazzard, W. R., Motulsky, A. G., and Bierman, E. L., 1975, Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities, Metabolism 24: 1115.
Carlson, L. A., and Böttiger, L. E., 1972, Ischemic heart disease in relation to fasting values of plasma triglycerides and cholesterol, Lancet 1: 865–868.
Carlson, L. A., Ekelund, L. G., and Olsson, A. G., 1975, Frequency of ischemic exercise E.C.G. changes in symptom-free men with various forms of primary hyperlipemia, Lancet 2: 1–3.
Casaretto, A., Goldsmith, R., Marchioro, T. L., and Bagdade, J. D., 1974, Hyperlipidemia after successful renal transplantation, Lancet 1: 481–484.
Connor, W. E., Stone, D. B., and Hodges, R. E., 1964, The interrelated effects of dietary cholesterol and fat upon human serum lipid levels, J. Clin. Invest. 43: 1691–1696.
Cooper, J., Geizerova, H., and Oliver, M. F., 1975, Clofibrate and gallstones, Lancet 1: 1083.
The Coronary Drug Project Research Group, 1975, Clofibrate and niacin in coronary heart disease, J. Amer. Med. Assoc. 231: 360–381.
Eisenberg, S., and Levy, R. I., 1975, Lipoprotein metabolism, in: Advances in Lipid Research, Vol. 13 ( R. Paoletti and D. Kritchevsky, eds.), pp. 1–89, Academic Press, New York.
Eisenberg, S., Bilheimer, D. W., Levy, R. I., and Lindgren, F. T., 1973, On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein, Biochim. Biophys. Acta 326: 361–377.
Fogelman, A. M., Edmond, J., Seager, J., and Popjak, G., 1975, Abnormal induction of 3-hvdroxy-3-methylglutarvl coenzyme A reductase in leukocytes from subjects with heterozygous familial hypercholesterolemia, J. Biol. Chem. 250: 2045–2055.
Fredrickson, D. S., 1975, Editorial: It’s time to be practical, Circulation 51: 20–9211.
Fredrickson, D. S., Levy, R. I., and Lees, R. S., 1967, Fat transport in lipoproteins—An integrated approach to mechanisms and disorders, N. Engl. J. Med. 276: 34.
Fredrickson, D. S., Morganroth, J., and Levy, R. I., 1975, Type III hyperlipoproteinemia: An analysis of two contemporary definitions, Ann. Intern. Med. 82: 150–157.
Glomset, J. A., and Norum, K. R., 1973, The metabolic role of lecithin:cholesterol acyltransferase: Perspectives from pathology, Adv. Lipid Res. 11: 1–65.
Glomset, J. A., Norum, K. R., Nichols, A. V., King, W. C., Mitchell, C. D., Applegate, K. R., Gong, E. L., and Gjone, E., 1975, Plasma lipoproteins in familial lecithin:cholesterol acyltransferase deficiency: Effects of dietary manipulation, Scand J. Clin. Lab. Invest. 35 (Suppl. 142): 3–30.
Goldstein, J. L., and Brown, M. S., 1975, Hyperlipidemia in coronary heart disease: A biochemical genetic approach, J. Lab. Clin. Med. 85: 15–25.
Goldstein, J. L., Hazzard, W. R., Bierman, E. L., Schrott, H. G., and Motulsky, A. G., 1973a, Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction, J. Clin. Invest. 52: 1533–1543.
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., and Motulsky, A. G., 1973b, Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia, J. Clin. Invest. 52: 1544–1568.
Goldstein, J. L., Brunschede, G. Y., and Brown, M. S., 1975a, Inhibition of the proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339, J. Biol. Chem. 250: 7854–7862.
Goldstein, J. L., Dana, S. E., Brunschede, G. Y., and Brown, M. S., 1975b, Genetic heterogeneity in familial hypercholesterolemia: Evidence for two different mutations affecting functions of low-density lipoprotein receptor, Proc. Nat. Acad. Sci. U.S.A. 72: 1092–1096.
Goldstein, J. L., Dana, S. E., Faust, J. R., Beaudet, A. L., and Brown, M. S., 1975c, Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein: Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease, J. Biol. Chem. 250: 8487–8495.
Hall, Y., Stamler, J., Cohen, D. B., Mojonnier, L., Epstein, M. B., Berkson, D. M., Whipple, I. T., and Catchings, S., 1972, Effectiveness of a low saturated fat, low cholesterol, weight-reducing diet for the control of hypertriglyceridemia, Atherosclerosis 16: 389–403.
Havel, R. J., 1975, Editorial: Hyperlipoproteinemia: Problems in diagnosis and challenges posed by the “type III” disorder, Ann. Intern. Med. 82: 273, 274.
Hazzard, W. R., and Bierman, E. L., 1975a, Broad-ß disease versus endogenous hypertriglyceridemia: Levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia, Metabolism 24: 817–828.
Hazzard, W. R., and Bierman, E. L., 1975b, The spectrum of electrophoretic mobility of very low density lipoproteins: Role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-ß disease (type III), I. Lab. Clin. Med. 86: 239–252.
Hazzard, W. R., Goldstein, J. L., Schrott, H. G., Motulsky, A. G., and Bierman, E. L., 1973, Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction, J. Clin. Invest. 52: 1569–1577.
Hazzard, W. R., O’Donnell, T. F., and Lee, Y. L., 1975, Broad-ß disease (type III hyperlipoproteinemia) in a large kindred: Evidence for a monogenic mechanism, Ann. Intern. Med. 82: 141–149.
Jackson, R. L., Sparrow, J. T., Baker, H. N., Morrisett, J. D., Taunton, O. D., and Gotto, A. M., Jr., 1974, The primary structure of apolipoprotein-serine, J. Biol. Chem. 249: 5308–5313.
Kane, J. P., Sata, T., Hamilton, R. L., and Havel, R. J., 1975, Apoprotein composition of very low density lipoproteins of human serum, J. Clin. Invest. 56: 1622–1634.
Kannel, W. B., Dawber, T. R., Kagan, A., Revotskie, N., and Stokes, J., III, 1961, Factors of risk in the development of coronary heart disease—Six year follow-up experience. The Framingham study, Ann. Intern. Med. 55: 33–50.
Kannel, W. B., Castelli, W. P., Gordon, T., and McNamara, P. M., 1971, Serum cholesterol, lipoproteins and the risk of coronary heart disease, Ann. Intern. Med. 74: 1–12.
Kaufmann, R. L., Assal, J. Ph., Soeldner, J. S., Wilmshurst, E. G., Lemaire, J. R., Gleason, R. E., and White, P., 1975, Plasma lipid levels in diabetic children. Effect of diet restricted in cholesterol and saturated fats, Diabetes 24: 67 2679.
Keys, A., 1975, Coronary heart disease—The global picture, Atherosclerosis 22: 149–192.
Khachadurian, A. K., Lipson, M., and Kawahara, F. S., 1975, Diagnosis of familial hypercholesterolemia by measurement of sterol synthesis in cultured skin fibroblasts, Atherosclerosis 21: 235–244.
Krogh, L., and Wickens, J. T., 1974, Portacaval shunt for hypercholesterolemia, S. Afr. Med. J. 48: (56): 2302.
Lees, R. S., and Wilson, D. E., 1971, The treatment of hyperlipidemia, N. Engl. J. Med. 284: 186–195.
Levy, R. I., Morganroth, J., and Rifkind, B. M., 1974, Drug therapy. Treatment of hyperlipidemia, N. Engl. J. Med. 290: 1295–1301.
Lindner, A., Charra, B., Sherrard, D. J., and Scribner, B. H., 1974, Accelerated atherosclerosis in prolonged maintenance hemodialysis, N. Engl. J. Med. 290: 697–701.
Lux, S. E., John, K. M., Ronan, R., and Brewer, H. B., Jr., 1972, Isolation and characterization of the tryptic and cyanogen bromide peptides of ApoLy-Gln II (Apo-II), a plasma high density apolipoprotein, J. Biol. Chem. 247: 7519–7527.
Mattson, F. H., Erickson, B. A., and Kligman, A. M., 1972, Effect of dietary cholesterol on serum cholesterol in man, Amer. J. Clin. Nutr. 25: 589–594.
Mattson, F. H., Hollenbach, E. J., and Kligman, A. M., 1975, Effect of hydrogenated fat on the plasma cholesterol and triglyceride levels of man, Amer. J. Clin. Nutr. 28: 726–731.
McCosh, E. J., Solangi, K., Rivers, J. M., and Goodman, A., 1975, Hypertriglyceridemia in patients with chronic renal insufficiency, Amer. J. Clin. Nutr. 28: 1036–1043.
Mishkel, M. A., Nazir, D. J., and Crowther, S., 1975, A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinemia, Clin. Chim. Acta 58: 121–136.
Mitchell, S., and Levy, R. I., 1974, Portacaval shunt in familial hypercholesterolemia, Lancet 2: 1263–1264.
Morganroth, J:, Levy, R. I., and Fredrickson, D. S., 1975, The biochemical, clinical, and genetic features of type III hyperlipoproteinemia, Ann. Intern. Med. 82: 158–174.
Morrisett, J. D., Jackson, R. L., and Gotto, A. M., Jr., 1975, Lipoproteins: Structure and function, Annu. Rev. Biochem. 44: 183–207.
Nikkilä, E. A., and Aro, A., 1973, Family study of serum lipids and lipoproteins in coronary heart disease, Lancet 1: 954–959.
Norum, K. R., Glomset, J. A., Nichols, A. V., Forte, T., Albers, J. J., King, W. C., Mitchell, C. D., Applegate, K. R., Gong, E. L., Cabana, V., and Gjone, E., 1975, Plasma lipoproteins in familial lecithin:cholesterol acyltransferase deficiency: Effects of incubation with lecithin:cholesterol acyltransferase in vitro, Scand. J. Clin. Lab. Invest. 35 (Suppl. 142): 31–55.
Patsch, J. R., Sailer, S., and Braunsteiner, H., 1975, Lipoprotein of the density 1.006–1.020 in the plasma of patients with type III hyperlipoproteinemia in the postabsorptive state, Eur. J. Clin. Invest. 5: 45–55.
Pierides, A. M., Alvarez-Ude, F., Kerr, D. N. S., and Skillen, A. W., 1975, Clofibrate-induced muscle damage in patients with chronic renal failure, Lancet 2: 1279–1282.
Rose, H. G., Kranz, P., Weinstock, M., Juliano, J., and Haft, J. I., 1973, Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype, Amer. J. Med. 54: 148–160.
Shulman, R. S., Herbert, P. N., Wehrly, K., and Fredrickson, D. S., 1975, The complete amino acid sequence of C-I (ApoLpSer), an apolipoprotein from human very low density lipoproteins, J. Biol. Chem. 250: 182–190.
Sigler, G. F., Soutar, A., Gotto, A. M., Jr., and Sparrow, J. T., 1975, The total synthesis of apolipoprotein-C-I, Circulation 52 (Suppl. II): 11–17.
Sigurdsson, G., Nicoll, A., and Lewis, B., 1975, Conversion of very low density lipoprotein to low density lipoprotein: A metabolic study of apolipoprotein B kinetics in human subjects, J. Clin. Invest. 56: 1481–1490.
Simons, L. A., Reichl, D., Myant, N. B., and Mancini, M., 1975, The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinemia in the homozygous form, Atherosclerosis 21: 283–298.
Slack, J., 1969, Risks of ischemic heart disease in familial hyperlipoproteinemia states, Lancet 2: 1380–1382.
Starzl, T. E., Putnam, C. W., Chase, H. P., and Porter, K. A., 1973, Portacaval shunt in hyperlipoproteinemia, Lancet 2: 940–944.
Starzl, T. E., Chase, H. P., Putnam, C. W., Nora, J. J., Fennell, R. H., Jr., and Porter, K. A., 1974, Portacaval shunt in hyperlipidemia, Lancet 2: 1263.
Stein, E. A., Mieny, C., Spitz, L., Saaron, I., Pettifor, J., Heimann, K. W., Bersohn, I., and Dinner, M., 1975, Portacaval shunt in four patients with homozygous hypercholesterolemia, Lancet 1: 832–835.
Stone, N. J., Levy, R. I.,.Fredrickson, D. S., and Verter, J., 1974, Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia, Circulation 49: 476–488.
Teisberg, P., Gjone, E., and Olaisen, B., 1975, Genetics of LCAT (lecithin:cholesterol acyltransferase) deficiency, Ann. Hum. Genet. London 38: 327–331.
Thompson, G. R., Lowenthal, R., and Myant, N. B., 1975, Plasma exchange in the management of homozygous familial hypercholesterolemia, Lancet 1: 1208–1211.
Torsvik, H., Fischer, J. E., Feldman, H. A., and Lees, R. S., 1975, Effects of intravenous hyperalimentation on plasma-lipoproteins in severe familial hypercholesterolemia, Lancet 1: 601–604.
Wilson, W. S., Hulley, S. B., Burrows, M. I., and Nichaman, M. Z., 1971, Serial lipid and lipoprotein responses to the American Heart Association fat-controlled diet, Amer. J. Med. 51: 491–503.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Publishing Corporation
About this chapter
Cite this chapter
Goodman, D.S. (1976). Disorders of Lipid and Lipoprotein Metabolism. In: Freinkel, N. (eds) The Year in Metabolism 1975–1976. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7656-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7656-9_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7658-3
Online ISBN: 978-1-4684-7656-9
eBook Packages: Springer Book Archive